Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2015	Aug. 31, 2014	Aug. 31, 2015	Aug. 31, 2014
Revenue
Revenue
Total revenue
OPERATING EXPENSES
General & administrative	$ 1,076,032	$ 1,267,176	$ 2,024,928	$ 1,802,677
Research & development	317,968	479,635	537,294	732,717
Total Operating Expenses	1,394,000	1,746,811	2,562,222	2,535,394
OTHER EXPENSES (INCOME)
Interest expense	$ 40,444	217,860	$ 45,361	618,606
Deferred financing costs amortization		15,131		60,523
Other income, net	$ (139,967)	(522)	$ (140,136)	(3,159)
Beneficial conversion feature		$ 2,324,760		$ 2,324,760
Change in fair value of warrant liability	$ (36,400)		$ (172,900)
Change in fair value of put embedded in note payable	3,134		3,134
Settlement expense	660		39,097
Total Other Expenses (Income)	(132,129)	$ 2,557,229	(225,444)	$ 3,000,730
NET LOSS	(1,261,871)	(4,304,040)	(2,336,778)	(5,536,124)
Net loss	$ (1,261,871)	$ (4,304,040)	(2,336,778)	$ (5,536,124)
Deemed Dividend on Series B Preferred Stock issuance			(1,067,491)
Accrued dividends on Series B Preferred Stock	$ (69,205)		(124,467)
Loss attributable to common shareholders	$ (1,331,076)	$ (4,304,040)	$ (3,528,736)	$ (5,536,124)
Net loss per share, basic and diluted	$ (0.73)	$ (2.53)	$ (1.94)	$ (3.52)
Weighted average shares outstanding	1,823,003	1,702,820	1,816,136	1,572,171